Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.
暂无分享,去创建一个
P. Larson | J. Kurhanewicz | D. Vigneron | M. Ferrone | R. Bok | C. von Morze | Hsin-Yu Chen | J. Gordon | R. Sriram | Romelyn Delos Santos | Justin Delos Santos | Naeim Bahrami
[1] J Kurhanewicz,et al. Dynamic nuclear polarization of biocompatible (13)C-enriched carbonates for in vivo pH imaging. , 2016, Chemical communications.
[2] J. Hazle,et al. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. , 2015, Cancer research.
[3] L. Holmberg,et al. Serum lactate dehydrogenase and survival following cancer diagnosis , 2015, British Journal of Cancer.
[4] S. Barni,et al. Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies , 2015, Acta oncologica.
[5] F. Saad,et al. Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. , 2015, The Lancet. Oncology.
[6] John Kurhanewicz,et al. Hyperpolarized 13C MR for Molecular Imaging of Prostate Cancer , 2014, The Journal of Nuclear Medicine.
[7] A. Haase,et al. Apparent rate constant mapping using hyperpolarized [1–13C]pyruvate , 2014, NMR in biomedicine.
[8] Daniel B Vigneron,et al. Kinetic and perfusion modeling of hyperpolarized (13)C pyruvate and urea in cancer with arbitrary RF flip angles. , 2014, Quantitative imaging in medicine and surgery.
[9] J. Kurhanewicz,et al. Endorectal MRI and MR spectroscopic imaging of prostate cancer: Developing selection criteria for MR‐guided focal therapy , 2014, Journal of magnetic resonance imaging : JMRI.
[10] Hessel Wijkstra,et al. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.
[11] Adam B Kerr,et al. Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon‐13 MRS , 2014, Magnetic resonance in medicine.
[12] J. Berwick,et al. Kinetic modeling of hyperpolarized 13C pyruvate metabolism in tumors using a measured arterial input function , 2013, Magnetic resonance in medicine.
[13] J. Pouysségur,et al. Disrupting proton dynamics and energy metabolism for cancer therapy , 2013, Nature Reviews Cancer.
[14] P. Larson,et al. Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.
[15] John Kurhanewicz,et al. Metabolic Reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor , 2013, The Prostate.
[16] Jason C. Crane,et al. SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows , 2013, Int. J. Biomed. Imaging.
[17] M. Giger,et al. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. , 2013, Radiology.
[18] Robert J Gillies,et al. Acidity generated by the tumor microenvironment drives local invasion. , 2013, Cancer research.
[19] C. Ménard,et al. Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer , 2012, Clinical Cancer Research.
[20] P. Porporato,et al. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. , 2012, Current pharmaceutical design.
[21] R. Deberardinis,et al. Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.
[22] J. Kurhanewicz,et al. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model , 2011, Cancer biology & therapy.
[23] A. Oto,et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. , 2011, AJR. American journal of roentgenology.
[24] Franziska Hirschhaeuser,et al. Lactate: a metabolic key player in cancer. , 2011, Cancer research.
[25] Shingo Matsumoto,et al. Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia. , 2011, Cancer research.
[26] M. Lustig,et al. Fast dynamic 3D MR spectroscopic imaging with compressed sensing and multiband excitation pulses for hyperpolarized 13C studies , 2011, Magnetic resonance in medicine.
[27] P. Larson,et al. Imaging of blood flow using hyperpolarized [13C]Urea in preclinical cancer models , 2011, Journal of magnetic resonance imaging : JMRI.
[28] John Kurhanewicz,et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.
[29] T. DeGrado,et al. ORIGINAL ARTICLE: Pilot comparison of 18F‐fluorocholine and 18F‐fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer , 2010, Journal of medical imaging and radiation oncology.
[30] John Kurhanewicz,et al. Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. , 2010, Journal of magnetic resonance.
[31] M. Lustig,et al. 3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer , 2010, Magnetic resonance in medicine.
[32] D. Mankoff,et al. Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient , 2009, Clinical Cancer Research.
[33] O. Feron,et al. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[34] Albert P. Chen,et al. Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.
[35] J. Kurhanewicz,et al. Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR‐MAS spectroscopy of biopsy tissues , 2008, Magnetic resonance in medicine.
[36] Guido Kroemer,et al. Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.
[37] John M Pauly,et al. Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. , 2007, Journal of magnetic resonance.
[38] E. T. Gawlinski,et al. Acid-mediated tumor invasion: a multidisciplinary study. , 2006, Cancer research.
[39] C. Dang,et al. Oncogenic alterations of metabolism and the Warburg effect , 2005 .
[40] Robert B Livingston,et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] R K Jain,et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.
[42] A. Lardner. The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.
[43] S. Bröer,et al. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.
[44] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[45] B. Foster,et al. Pathologic progression of autochthonous prostate cancer in the TRAMP model , 1999, Prostate Cancer and Prostatic Diseases.
[46] H. Coller. Is cancer a metabolic disease? , 2014, The American journal of pathology.
[47] Steven J. M. Jones,et al. A multi-institutional evaluation of active surveillance for low risk prostate cancer. , 2013, The Journal of urology.
[48] C. Nanni,et al. Positron-emission tomography in imaging and staging prostate cancer. , 2008, Cancer biomarkers : section A of Disease markers.
[49] Bing Zhang,et al. [Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significance]. , 2006, Zhonghua nan ke xue = National journal of andrology.